Single answer
Is Atossa Therapeutics Inc (ATOS) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Atossa Therapeutics Inc is $5.00, which is $4.38 (704.51%) above the current price today's price.
Low target: $5.00 | High target: $5.00
Company snapshot
A quick overview of the business and its public profile.
Atossa Therapeutics Inc a clinicalstage biopharmaceutical company focuses on the discovery and development of medicines in the areas of oncology and infectious diseases The companys lead program is Endoxifen an active metabolite of tamoxifen which is in Phase II clinical trials to treat and prevent breast cancer It is also developing ATH201 an inhalation therapy to improve lung function in severely ill and hospitalized COVID19 patients AT301 a proprietary drug candidate for nasal administration in patients diagnosed with COVID19 and immunotherapychimeric antigen receptor therapy programs for the treatment of breast cancer It has a research agreement with DanaFarber Cancer Institute Inc to support research of cytokinecoated nanoparticles for the treatment of breast cancer The company was formerly known as Atossa Genetics Inc and changed its name to Atossa Therapeutics Inc in January 2020 Atossa Therapeutics Inc was founded in 2008 and is headquartered in Seattle Washington
Website: https://www.atossatherapeutics.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.00. Cash flow to debt ratio: 0.00. Net profit margin: 0.00%. Inflation risk score: medium (0.60/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
No, the average daily trading liquidity for Atossa Therapeutics Inc is $763,439. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
10-year return check
On Atossa Therapeutics Inc, 2015-12-31 had a stock price of $57.60. If you invested back then, your return now would be a loss of $56.98 per share or 98.92%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.